JP2024517607A5 - - Google Patents

Info

Publication number
JP2024517607A5
JP2024517607A5 JP2023562936A JP2023562936A JP2024517607A5 JP 2024517607 A5 JP2024517607 A5 JP 2024517607A5 JP 2023562936 A JP2023562936 A JP 2023562936A JP 2023562936 A JP2023562936 A JP 2023562936A JP 2024517607 A5 JP2024517607 A5 JP 2024517607A5
Authority
JP
Japan
Application number
JP2023562936A
Other languages
Japanese (ja)
Other versions
JP2024517607A (ja
JPWO2022232638A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/027124 external-priority patent/WO2022232638A2/en
Publication of JP2024517607A publication Critical patent/JP2024517607A/ja
Publication of JPWO2022232638A5 publication Critical patent/JPWO2022232638A5/ja
Publication of JP2024517607A5 publication Critical patent/JP2024517607A5/ja
Pending legal-status Critical Current

Links

JP2023562936A 2021-04-30 2022-04-29 Ruvcドメインを有する酵素 Pending JP2024517607A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163182438P 2021-04-30 2021-04-30
US63/182,438 2021-04-30
PCT/US2022/027124 WO2022232638A2 (en) 2021-04-30 2022-04-29 Enzymes with ruvc domains

Publications (3)

Publication Number Publication Date
JP2024517607A JP2024517607A (ja) 2024-04-23
JPWO2022232638A5 JPWO2022232638A5 (https=) 2025-05-01
JP2024517607A5 true JP2024517607A5 (https=) 2025-05-01

Family

ID=83847352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023562936A Pending JP2024517607A (ja) 2021-04-30 2022-04-29 Ruvcドメインを有する酵素

Country Status (10)

Country Link
US (1) US20240110167A1 (https=)
EP (1) EP4330386A4 (https=)
JP (1) JP2024517607A (https=)
KR (1) KR20240004618A (https=)
CN (1) CN117203332A (https=)
AU (1) AU2022264921A1 (https=)
BR (1) BR112023022270A2 (https=)
CA (1) CA3214222A1 (https=)
MX (1) MX2023012606A (https=)
WO (1) WO2022232638A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3225082A1 (en) 2021-08-27 2023-03-02 Brian C. Thomas Enzymes with ruvc domains
MX2024006257A (es) 2021-11-24 2024-07-29 Metagenomi Inc Sistemas de endonucleasas.
AU2024339645A1 (en) * 2023-09-13 2026-04-23 Metagenomi Therapeutics, Inc. Engineered and chimeric nucleases
WO2025106934A1 (en) * 2023-11-16 2025-05-22 Metagenomi, Inc. Enzymes with ruvc domains

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2894684A1 (en) * 2012-12-12 2014-06-19 The Broad Institute, Inc. Engineering and optimization of improved crispr-cas systems, methods and enzyme compositions for sequence manipulation in eukaryotes
US9234213B2 (en) * 2013-03-15 2016-01-12 System Biosciences, Llc Compositions and methods directed to CRISPR/Cas genomic engineering systems
AU2018240515B2 (en) * 2017-03-24 2024-07-25 CureVac SE Nucleic acids encoding CRISPR-associated proteins and uses thereof
KR20200124702A (ko) * 2018-02-23 2020-11-03 파이어니어 하이 부렛드 인터내쇼날 인코포레이팃드 신규한 cas9 오르소로그
AU2020223370B2 (en) * 2019-02-14 2023-04-20 Metagenomi Therapeutics, Inc. Enzymes with RuvC domains
US10913941B2 (en) * 2019-02-14 2021-02-09 Metagenomi Ip Technologies, Llc Enzymes with RuvC domains

Similar Documents

Publication Publication Date Title
JP2024515936A5 (https=)
JP2024517607A5 (https=)
CL2025003743A1 (es) Composición farmacéutica que comprende maribavir.
CN307049748S (https=)
CN307045168S (https=)
BY13153U (https=)
BY13156U (https=)
CN307049661S (https=)
CN307048904S (https=)
CN307048619S (https=)
CN307048616S (https=)
CN307048212S (https=)
CN307047601S (https=)
CN307047342S (https=)
CN307047210S (https=)
CN307047066S (https=)
CN307046028S (https=)
CN307045787S (https=)
CN307045621S (https=)
CN307045521S (https=)
CN307044835S (https=)
CN307044507S (https=)
BY23965C1 (https=)
BY23963C1 (https=)
BY13175U (https=)